Latest advances in the management of facial synkinesis

Jeffrey D. Markey, Myriam Loyo

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Purpose of review: To provide an overview of the treatment options for nonflaccid facial paralysis including physical rehabilitation, botulinum toxin injection and surgical intervention. To also describe recent technique advances regarding facial synkinesis in each zone of facial movement. Recent findings: Physical therapy and neuromodulation with botulinum toxin continues to be the main treatment strategy for facial synkinesis. Treating the orbicularis oculi, mentalis and platysma muscles with neurotoxin has been well described. A symmetric smile can also be improved with ipsilateral depressor anguli oris and the contralateral depressor labi inferioris weakening. Novel surgical techniques to selectively ablate specific facial muscles have also been recently described. Summary: Nonflaccid facial paralysis is a spectrum of hypokinetic and hyperkinetic movement following facial nerve injury that is best treated in a patient-tailored graduated fashion. Novel techniques are evolving to maximize patient function while minimizing morbidity.

Original languageEnglish (US)
Pages (from-to)265-272
Number of pages8
JournalCurrent Opinion in Otolaryngology and Head and Neck Surgery
Volume25
Issue number4
DOIs
StatePublished - Aug 1 2017

Fingerprint

Synkinesis
Botulinum Toxins
Facial Paralysis
Facial Nerve Injuries
Facial Muscles
Hyperkinesis
Neurotoxins
Therapeutics
Rehabilitation
Morbidity
Injections

Keywords

  • botulinum toxin
  • nonflaccid facial paralysis
  • selective neurectomy
  • synkinesis

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Latest advances in the management of facial synkinesis. / Markey, Jeffrey D.; Loyo, Myriam.

In: Current Opinion in Otolaryngology and Head and Neck Surgery, Vol. 25, No. 4, 01.08.2017, p. 265-272.

Research output: Contribution to journalReview article

@article{0fbbc0cbbbee4e38a3c58b0c0a6a69c2,
title = "Latest advances in the management of facial synkinesis",
abstract = "Purpose of review: To provide an overview of the treatment options for nonflaccid facial paralysis including physical rehabilitation, botulinum toxin injection and surgical intervention. To also describe recent technique advances regarding facial synkinesis in each zone of facial movement. Recent findings: Physical therapy and neuromodulation with botulinum toxin continues to be the main treatment strategy for facial synkinesis. Treating the orbicularis oculi, mentalis and platysma muscles with neurotoxin has been well described. A symmetric smile can also be improved with ipsilateral depressor anguli oris and the contralateral depressor labi inferioris weakening. Novel surgical techniques to selectively ablate specific facial muscles have also been recently described. Summary: Nonflaccid facial paralysis is a spectrum of hypokinetic and hyperkinetic movement following facial nerve injury that is best treated in a patient-tailored graduated fashion. Novel techniques are evolving to maximize patient function while minimizing morbidity.",
keywords = "botulinum toxin, nonflaccid facial paralysis, selective neurectomy, synkinesis",
author = "Markey, {Jeffrey D.} and Myriam Loyo",
year = "2017",
month = "8",
day = "1",
doi = "10.1097/MOO.0000000000000376",
language = "English (US)",
volume = "25",
pages = "265--272",
journal = "Current Opinion in Otolaryngology and Head and Neck Surgery",
issn = "1068-9508",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Latest advances in the management of facial synkinesis

AU - Markey, Jeffrey D.

AU - Loyo, Myriam

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Purpose of review: To provide an overview of the treatment options for nonflaccid facial paralysis including physical rehabilitation, botulinum toxin injection and surgical intervention. To also describe recent technique advances regarding facial synkinesis in each zone of facial movement. Recent findings: Physical therapy and neuromodulation with botulinum toxin continues to be the main treatment strategy for facial synkinesis. Treating the orbicularis oculi, mentalis and platysma muscles with neurotoxin has been well described. A symmetric smile can also be improved with ipsilateral depressor anguli oris and the contralateral depressor labi inferioris weakening. Novel surgical techniques to selectively ablate specific facial muscles have also been recently described. Summary: Nonflaccid facial paralysis is a spectrum of hypokinetic and hyperkinetic movement following facial nerve injury that is best treated in a patient-tailored graduated fashion. Novel techniques are evolving to maximize patient function while minimizing morbidity.

AB - Purpose of review: To provide an overview of the treatment options for nonflaccid facial paralysis including physical rehabilitation, botulinum toxin injection and surgical intervention. To also describe recent technique advances regarding facial synkinesis in each zone of facial movement. Recent findings: Physical therapy and neuromodulation with botulinum toxin continues to be the main treatment strategy for facial synkinesis. Treating the orbicularis oculi, mentalis and platysma muscles with neurotoxin has been well described. A symmetric smile can also be improved with ipsilateral depressor anguli oris and the contralateral depressor labi inferioris weakening. Novel surgical techniques to selectively ablate specific facial muscles have also been recently described. Summary: Nonflaccid facial paralysis is a spectrum of hypokinetic and hyperkinetic movement following facial nerve injury that is best treated in a patient-tailored graduated fashion. Novel techniques are evolving to maximize patient function while minimizing morbidity.

KW - botulinum toxin

KW - nonflaccid facial paralysis

KW - selective neurectomy

KW - synkinesis

UR - http://www.scopus.com/inward/record.url?scp=85020700206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020700206&partnerID=8YFLogxK

U2 - 10.1097/MOO.0000000000000376

DO - 10.1097/MOO.0000000000000376

M3 - Review article

VL - 25

SP - 265

EP - 272

JO - Current Opinion in Otolaryngology and Head and Neck Surgery

JF - Current Opinion in Otolaryngology and Head and Neck Surgery

SN - 1068-9508

IS - 4

ER -